homovanillic acid has been researched along with scopolamine hydrobromide in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (68.75) | 18.7374 |
1990's | 2 (12.50) | 18.2507 |
2000's | 2 (12.50) | 29.6817 |
2010's | 1 (6.25) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, KL; Goodwin, FK; Gordon, EK; Hollister, LE | 1 |
Maitre, L; Waldmeier, PC | 1 |
Ahtee, L; Kaakkola, S | 1 |
Waldmeier, PC | 1 |
Crow, TJ; Deakin, JF; Longden, A | 1 |
McKenzie, G; Sarau, H; Setler, P | 1 |
Hashimoto, T; Koda, H; Kuriyama, K | 1 |
Memo, M; Missale, C; Spano, PF; Trivelli, L | 1 |
Fernando, JC; Ho, IK; Hoskins, B | 1 |
Andén, NE | 1 |
He, L; Xu, S | 1 |
Chai, BL; Meltzer, HY; Thompson, PA; Yamamoto, BK | 1 |
Iino, T; Katsura, M; Kuriyama, K | 1 |
Amoroso, S; Cassano, T; Castrignanò, S; Colaianna, M; Cuomo, V; Giustino, A; Steardo, L; Trabace, L | 1 |
Del Arco, A; Mora, F; Segovia, G | 1 |
Chen, L; Huang, L; Huang, X; Jiang, J; Li, S; Qiu, Y; Tang, L | 1 |
1 review(s) available for homovanillic acid and scopolamine hydrobromide
Article | Year |
---|---|
Caudate nucleus and acupuncture analgesia.
Topics: Acetylcholine; Acupuncture Therapy; Analgesia; Animals; Caudate Nucleus; Cerebral Ventricles; Cyclic AMP; Dopamine; Electric Stimulation; Homovanillic Acid; Hydroxydopamines; Naloxone; Rabbits; Scopolamine | 1981 |
1 trial(s) available for homovanillic acid and scopolamine hydrobromide
Article | Year |
---|---|
Neurotransmitter metabolites in the cerebrospinal fluid of man following physostigmine.
Topics: Adult; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neurotransmitter Agents; Physostigmine; Probenecid; Scopolamine | 1977 |
14 other study(ies) available for homovanillic acid and scopolamine hydrobromide
Article | Year |
---|---|
Effects of baclofen on dopamine metabolism and interaction with neuroleptic effects.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aminobutyrates; Animals; Antipsychotic Agents; Baclofen; Benserazide; Carboxy-Lyases; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Drug Interactions; Female; Homovanillic Acid; Limbic System; Male; Methyltyrosines; Picrotoxin; Rats; Scopolamine | 1978 |
Effect of muscarinic cholinergic drugs on morphine-induced catalepsy, antinociception and changes in brain dopamine metabolism.
Topics: Analgesia; Animals; Body Temperature; Brain; Catalepsy; Corpus Striatum; Dopamine; Drug Interactions; Female; Homovanillic Acid; Humans; Male; Methyltyrosines; Morphine; Norepinephrine; Parasympatholytics; Parasympathomimetics; Pilocarpine; Rats; Scopolamine; Time Factors | 1977 |
Analysis of the activation of dopamine metabolism by a serotonin uptake inhibitor.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Baclofen; Benzofurans; Corpus Striatum; Dopamine; Female; Haloperidol; Homovanillic Acid; Piperidines; Rats; Scopolamine; Serotonin Antagonists; Time Factors | 1979 |
The nucleus accumbens--possible site of antipsychotic action of neuroleptic drugs?
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benztropine; Chlorpromazine; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Fluphenazine; Homovanillic Acid; Humans; Male; Psychotic Disorders; Rats; Receptors, Dopamine; Scopolamine; Tegmentum Mesencephali; Thioridazine; Tranquilizing Agents | 1977 |
Differential attenuation of some effects of haloperidol in rats given scopolamine.
Topics: Amphetamine; Animals; Avoidance Learning; Catalepsy; Corpus Striatum; Dose-Response Relationship, Drug; Haloperidol; Homovanillic Acid; Humans; Male; Motor Activity; Rats; Rats, Inbred F344; Scopolamine; Stereotyped Behavior | 1976 |
Muscarinic receptor-mediated regulation of OM-853-enhanced dopamine release in striatum of rat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alkaloids; Animals; Apomorphine; Atropine; Carbachol; Corpus Striatum; Dopamine; Homovanillic Acid; In Vitro Techniques; Male; Quinuclidinyl Benzilate; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Scopolamine; Vinca Alkaloids | 1989 |
Acute scopolamine treatment decreases dopamine metabolism in rat hippocampus and frontal cortex.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Avoidance Learning; Cerebral Cortex; Dopamine; Hippocampus; Homovanillic Acid; Male; Rats; Rats, Inbred Strains; Scopolamine | 1988 |
The role of dopamine in behavioral supersensitivity to muscarinic antagonists following cholinesterase inhibition.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Atropine; Behavior, Animal; Cholinesterase Inhibitors; Dopamine; Homovanillic Acid; Isoflurophate; Male; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Scopolamine | 1986 |
Effects of oxotremorine and physostigmine on the turnover of dopamine in the corpus striatum and the limbic system.
Topics: Animals; Brain Chemistry; Corpus Striatum; Dopamine; Homovanillic Acid; Limbic System; Oxotremorine; Physostigmine; Rabbits; Scopolamine; Trihexyphenidyl | 1974 |
Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biological Transport; Clozapine; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Male; Microdialysis; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Scopolamine; Thioridazine | 1994 |
Effect of vinconate on the extracellular levels of dopamine and its metabolites in the rat striatum: microdialysis studies.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Male; Muscarinic Antagonists; Rats; Rats, Wistar; Scopolamine; Vinca Alkaloids | 1995 |
Neurochemical and neurobehavioral effects of ganstigmine (CHF2819), a novel acetylcholinesterase inhibitor, in rat prefrontal cortex: an in vivo study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Administration, Oral; Alkaloids; Analysis of Variance; Animals; Carbamates; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Dopamine; Exploratory Behavior; Extracellular Space; Homovanillic Acid; Male; Memory; Norepinephrine; Prefrontal Cortex; Rats; Rats, Wistar; Scopolamine; Serotonin | 2007 |
Blockade of NMDA receptors in the prefrontal cortex increases dopamine and acetylcholine release in the nucleus accumbens and motor activity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Cholinergic Antagonists; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Flupenthixol; Glutamic Acid; Homovanillic Acid; Injections, Intraventricular; Male; Mecamylamine; Microinjections; Motor Activity; Muscarinic Antagonists; N-Methylaspartate; Nicotinic Antagonists; Nucleus Accumbens; Piperazines; Prefrontal Cortex; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Scopolamine | 2008 |
5-HT(1A) receptor antagonist improves behavior performance of delirium rats through inhibiting PI3K/Akt/mTOR activation-induced NLRP3 activity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Basolateral Nuclear Complex; Emergence Delirium; Gene Expression Regulation; Hippocampus; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Injections, Intraventricular; Interleukin-1beta; Male; Maze Learning; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Proto-Oncogene Proteins c-akt; Pyridines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Scopolamine; Serotonin; Serotonin Antagonists; Signal Transduction; Stereotaxic Techniques; TOR Serine-Threonine Kinases | 2016 |